Serum CA125 levels predict outcome of interval debulking surgery after neoadjuvant chemotherapy in patients with advanced ovarian cancer

Cancer statistics, 2015

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

William E. Winter, G. Larry Maxwell, Chunqiao Tian et al. · Journal of Clinical Oncology · 2007 · 846 citations · Full text

Medicine, Gynecology, Oncology +15

A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma

S. Dennis, Oliver Zivanovic, Meena J. Palayekar et al. · Gynecologic Oncology · 2008 · 90 citations

Medicine, Gynecology, Surgery +14

Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer

Marco Petrillo, Gian Franco Zannoni, Lucia Tortorella et al. · American Journal of Obstetrics and Gynecology · 2014 · 79 citations

Medicine, Gynecology, Oncology +17

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

Noah Rodriguez, J. Alejandro Rauh‐Hain, Melina Shoni et al. · Gynecologic Oncology · 2012 · 76 citations

Medicine, Gynecology, Oncology +17